Amanote Research
Register
Sign In
6. Novel Cardiac-Tropic AAV Vectors by DNA Shuffling and in Vivo Screening
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37447-0
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
Directed Evolution of a Fucosidase From a Galactosidase by DNA Shuffling and Screening
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Naturally Enveloped AAV Vectors for Shielding Neutralizing Antibodies and Robust Gene Delivery in Vivo
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Novel Adenovirus Vaccine Vectors Based on the Enteric-Tropic Serotype 41
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Capsid-Expressing DNA in AAV Vectors and Its Elimination by Use of an Oversize Capsid Gene for Vector Production
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
28. Mouse and Pig Photoreceptor Transduction Mediated by Triple AAV Vectors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
High-Throughput Screening Identifies Kinase Inhibitors That Increase Dual AAV Vectors Transduction in Vitro and in Mouse Retina
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
Frontiers in Oncology
Cancer Research
Oncology
Enhanced Catalytic Efficiency of CotA-laccase by DNA Shuffling
Bioengineered
Applied Microbiology
Biotechnology
Medicine
Bioengineering
1. Genome-Wide RNAi Screening Identifies Host Restriction Factors Critical for in Vivo AAV Transduction
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery